Lipid profile is associated with the incidence of cognitive dysfunction in viral cirrhotic patients: A data-mining analysis

Hepatology Research

Volumn 43, Issue 4, 2013, Pages 418-424

  Taniguchi, Eitaro ^a   Kawaguchi, Takumi ^a,b   Sakata, Masahiro ^a   Itou, Minoru ^a   Oriishi, Tetsuharu ^a   Sata, Michio ^a,b  

^a Division of Gastroenterology   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Decision tree algorithm; Fatty acid; Minimal hepatic encephalopathy; Neuropsychiatric test

Indexed keywords

BILIRUBIN; FATTY ACID; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; DECISION TREE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LIPID ANALYSIS; LIVER CIRRHOSIS; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84876099081     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01076.x     Document Type: Article

References (58)

1. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38.
2. Rossi S, Ravetta V, Rosa L etal. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 2011; 53: 136-47.
3. Kato A, Kato M, Ishii H etal. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese. Hepatol Res 2004; 30: 71-8.
4. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42: S45-53.
5. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
6. Dhiman RK, Saraswat VA, Sharma BK etal. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol 2010; 25: 1029-41.
7. Bao ZJ, Qiu DK, Ma X etal. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13: 3003-8.
8. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
9. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011; 106: 307-16.
10. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-45.
11. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 1903-9.
12. Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14: 3609-15.
13. Bajaj JS, Saeian K, Schubert CM etal. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009; 50: 1175-83.
14. Roman E, Cordoba J, Torrens M etal. Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol 2011; 106: 476-82.
15. Soriano G, Roman E, Cordoba J etal. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012; 55: 1922-30.
16. Bajaj JS, Pinkerton SD, Sanyal AJ, Heuman DM. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology 2012; 55: 1164-71.
17. Gupta A, Dhiman RK, Kumari S etal. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010; 53: 849-55.
18. Watanabe A, Sakai T, Sato S etal. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26: 1410-14.
19. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-38.
20. Haussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008; 57: 1156-65.
21. Bajaj JS, Heuman DM, Wade JB etal. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011; 140: 478-87. e1.
22. Luo M, Li L, Lu CZ, Cao WK. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 2011; 23: 1250-7.
23. Blei AT, Cordoba J. Subclinical encephalopathy. Dig Dis 1996; 14 (Suppl 1): 2-11.
24. Kachaamy T, Bajaj JS. Diet and cognition in chronic liver disease. Curr Opin Gastroenterol 2011; 27: 174-9.
25. Kawaguchi T, Kakuma T, Yatsuhashi H etal. Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2011; 41: 564-71.
26. Otsuka M, Uchida Y, Kawaguchi T etal. Fish to meat intake ratio and cooking oils are associated with hepatitis C virus carriers with persistently normal alanine aminotransferase levels. Hepatol Res 2012; in press.
27. Lee A, Joynt GM, Ho AM, Keitz S, McGinn T, Wyer PC. Tips for teachers of evidence-based medicine: making sense of decision analysis using a decision tree. J Gen Intern Med 2009; 24: 642-8.
28. Kurosaki M, Matsunaga K, Hirayama I etal. A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis. Hepatol Res 2010; 40: 251-60.
29. Hashem AM, Rasmy ME, Wahba KM, Shaker OG. Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection. Comput Methods Programs Biomed 2012; 105: 194-209.
30. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res 2009; 39: 107-16.
31. Nakayama N, Oketani M, Kawamura Y etal. Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees. J Gastroenterol 2012; 47: 644-77.
32. Michitaka K, Tokumoto Y, Uesugi K etal. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatol Res 2008; 38: 1069-75.
33. Kawaguchi T, Sakisaka S, Sata M, Mori M, Tanikawa K. Different lobular distributions of altered hepatocyte tight junctions in rat models of intrahepatic and extrahepatic cholestasis. Hepatology 1999; 29: 205-16.
34. Kawaguchi T, Yoshida T, Harada M etal. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165: 1499-508.
35. Butterworth RF. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol 2003; 39: 278-85.
36. Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 677-85.
37. Randolph C, Hilsabeck R, Kato A etal. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 629-35.
38. Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011; 53: 1372-6.
39. Vaisman N, Katzman H, Carmiel-Haggai M, Lusthaus M, Niv E. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr 2010; 92: 137-40.
40. Spector AA. Fatty acid binding to plasma albumin. J Lipid Res 1975; 16: 165-79.
41. Oida T. 1H-NMR study on the interactions of human serum albumin with free fatty acid. J Biochem 1986; 100: 1533-42.
42. Soltys BJ, Hsia C. Human serum albumin. I. On the relationship of fatty acid and bilirubin binding sites and the nature of fatty acid allosteric effects-a monoanionic spin label study. J Biol Chem 1978; 253: 3023-8.
43. Fernstrom JD, Fernstrom MH. Exercise, serum free tryptophan, and central fatigue. J Nutr 2006; 136: 553S-9S.
44. Lal S, Young SN, Sourkes TL. Letter: 5-hydroxytryptamine and hepatic coma. Lancet 1975; 2: 979-80.
45. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R. Tryptophan and hepatic coma. Gastroenterology 1978; 74: 196-200.
46. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999; 283: 397-401.
47. Farr SA, Yamada KA, Butterfield DA etal. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008; 149: 2628-36.
48. Raffaitin C, Feart C, Le Goff M etal. Metabolic syndrome and cognitive decline in French elders: the Three-City Study. Neurology 2011; 76: 518-25.
49. Yaffe K. Metabolic syndrome and cognitive decline. Curr Alzheimer Res 2007; 4: 123-6.
50. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982; 36: 950-62.
51. Lantos PL, Aminoff MJ. Fine structural changes in the sural nerve of patients with acanthocytosis. Acta Neuropathol 1972; 22: 257-63.
52. Buonuomo PS, Ruggiero A, Valeriani M, Mariotti P. Familial hypobetalipoproteinemia: early neurological, hematological, and ocular manifestations in two affected twins responding to vitamin supplementation. Curr Opin Pediatr 2009; 21: 824-7.
53. Reger MA, Henderson ST, Hale C etal. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004; 25: 311-14.
54. Butterworth RF. Editorial: rifaximin and minimal hepatic encephalopathy. Am J Gastroenterol 2011; 106: 317-18.
55. Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol 2008; 103: 1674-81.
56. Soriano G, Roman E, Cordoba J etal. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012; 55: 1922-30.
57. Kato A, Watanabe Y, Sawara K, Suzuki K. Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests). Hepatol Res 2008; 38: S122-S7.
58. Amodio P, Campagna F, Olianas S etal. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49: 346-53.